GE HealthCare Technologies Inc.
GEHC
Pozycja w akcjach
#773
GE HealthCare Technologies Inc. is a global medical technology company that... GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Cena akcji
$69.84
Kapitalizacja rynkowa
$31.55B
Zmiana (1 dzień)
0.39%
Zmiana (1 rok)
-5.69%
Kraj
US
Handel GE HealthCare Technologies Inc. (GEHC)
Kategoria
Healthcare
Marża operacyjna dla GE HealthCare Technologies Inc. (GEHC)
Marża operacyjna na dzień October 2026 TTM: 12.70%
Według najnowszych raportów finansowych i ceny akcji GE HealthCare Technologies Inc., bieżąca marża operacyjna (TTM) wynosi 12.70%. Na koniec 2024 wynosiła 13.34%.
Historia marży operacyjnej dla GE HealthCare Technologies Inc. od 2019 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 12.70% | -4.30% |
| 2025 | 13.27% | -0.52% |
| 2024 | 13.34% | 7.15% |
| 2023 | 12.45% | -9.45% |
| 2022 | 13.75% | -13.47% |
| 2021 | 15.89% | 0.25% |
| 2020 | 15.85% | 24.12% |
| 2019 | 12.77% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 74.94% | -94.10% |
AU
|
|
| 3.33% | -99.74% |
US
|
|
| -19.76% | -101.56% |
US
|
|
| -14.33% | -101.13% |
US
|
|
| 0.00% | - |
US
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.